Documentation
Testing & COAs
Search batch-level documentation by product name, product code, or lot number.
| Product | Product Code | Lot Number | Strength | Purity | Test Date | Document |
|---|---|---|---|---|---|---|
| BPC-157 | PB-001 | PB001-2603A-A | 5mg | ≥ 99.9% | 2026-03-12 | |
| BPC-157 | PB-001 | PB001-2603A-B | 10mg | ≥ 99.9% | 2026-03-12 | |
| GHK-Cu | PB-003 | PB003-2603C-A | 50mg | ≥ 99.9% | 2026-03-04 | |
| GHK-Cu | PB-003 | PB003-2603C-B | 100mg | ≥ 99.9% | 2026-03-04 | |
| GHK-Cu | PB-003 | PB003-2603C-C | 200mg | ≥ 99.9% | 2026-03-04 | |
| GLP-3 | PB-002 | PB002-2602B-A | 10mg | ≥ 99.9% | 2026-02-28 | |
| GLP-3 | PB-002 | PB002-2602B-B | 20mg | ≥ 99.9% | 2026-02-28 | |
| GLP-3 | PB-002 | PB002-2602B-C | 30mg | ≥ 99.9% | 2026-02-28 | |
| GLP-3 | PB-002 | PB002-2602B-D | 60mg | ≥ 99.9% | 2026-02-28 | |
| Semax | PB-004 | PB004-2601D-A | 10mg | ≥ 99.9% | 2026-01-19 | |
| Semax | PB-004 | PB004-2601D-B | 30mg | ≥ 99.9% | 2026-01-19 | |
| Semax | PB-004 | PB004-2601D-C | 60mg | ≥ 99.9% | 2026-01-19 | |
| MOTS-C | PB-005 | PB005-2602E-A | 5mg | ≥ 99.9% | 2026-02-08 | |
| MOTS-C | PB-005 | PB005-2602E-B | 10mg | ≥ 99.9% | 2026-02-08 | |
| MOTS-C | PB-005 | PB005-2602E-C | 20mg | ≥ 99.9% | 2026-02-08 | |
| NAD+ | PB-006 | PB006-2603F-A | 250mg | ≥ 99.9% | 2026-03-01 | |
| NAD+ | PB-006 | PB006-2603F-B | 500mg | ≥ 99.9% | 2026-03-01 | |
| NAD+ | PB-006 | PB006-2603F-C | 1000mg | ≥ 99.9% | 2026-03-01 | |
| Tesamorelin | PB-007 | PB007-2606G-A | 2mg | ≥ 99.9% | 2026-06-20 | |
| Tesamorelin | PB-007 | PB007-2606G-B | 5mg | ≥ 99.9% | 2026-06-20 | |
| Tesamorelin | PB-007 | PB007-2606G-C | 10mg | ≥ 99.9% | 2026-06-20 |
Testing documentation applies only to the specific batch and lot number listed. Product documentation is provided for laboratory research recordkeeping and verification purposes.